-- 加拿大皇家銀行資本市場（RBC Capital Markets）週三發布的研究報告指出，未來兩到三年，得益於生成式人工智慧（AI）需求和記憶體供應緊張，晶圓製造設備市場環境良好，Lam Research (LRCX)有望從中受益。 該券商表示，已將Lam Research 2026財年和2027財年的每股盈餘預期分別從先前的5.30美元和6.84美元上調至5.65美元和7.72美元。 分析師指出，該公司第三財季業績超預期主要得益於DRAM業務的強勁表現以及高頻寬記憶體市場持續成長帶動NAND快閃前景的改善。 報告也指出，該公司第三財季在中國的業務佔比有所下降，並預計隨著全球支出加速成長，這一佔比將進一步下降，但總體而言，中國市場需求依然穩定。 加拿大皇家銀行重申了對該股的「跑贏大盤」評級，並將目標價從290美元上調至310美元。
Price: $261.88, Change: $-3.68, Percent Change: -1.38%
Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.
Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.
Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.